NCT07455032 · Interventional trial
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
Overall registry status Recruiting
Phase 1
Conditions Squamous Cell Carcinoma of Head and Neck
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
- Temple University Hospital · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory